On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Viral dynamics in patients on antiretroviral drugs
- A resting CD4+ T cell
- Resting/activated/infected CD4+ T cells
- NFkappaB sites in the HIV LTR
- Establishment/maintenance of latent reservoir
- Frequency of latently infected CD4+ T cells (1)
- Residual viremia and blips - HAART patients (1)
- Frequency of latently infected CD4+ T cells (2)
- Dynamics of the latent pool
- Archival WT/drug resistance in latent reservoir
- HIV evolution
- Persistence of drug resistant variants - example
- Assay for latent HIV in viremic patients
- Archived nevirapine resistance
- Residual viremia and blips - HAART patients (2)
- Analysis of residual viremia in HAART patients
- Results of residual viremia analysis
- Theories regarding the blips in HAART patients
- Analysis of blips with frequent sampling
- No new mutations during blips
- Blips don't represent elevations in viremia
- Additional source of residual viremia
- Detection of predominant plasma sequence (1)
- Detection of predominant plasma sequence (2)
- Why wasn't this phenomenon seen before?
- Predominant plasma clone (PPC)
- Characteristics of the PPC
- Hypothesis on the origin of the PPCs
- PPC and stability of the latent reservoir
- Latent reservoir is not replenished by replication
- Conclusions
Topics Covered
- Viral dynamics in patients on antiretroviral drugs
- CD4+ T-cells
- Response of resting T-cells to AG
- Establishment and maintenance of a latent reservoir
- Dynamics of the latent pool
- HIV evolution
- HAART
- Residual viremia and blips on patients on HAART
- The nature of blips
- Blips do not represent clinically significant elevations in viremia
- Characteristics of the PPC
- The latent reservoir is not replenished by ongoing viral replication in patients on HAART
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Siliciano, R. (2007, October 1). Viral reservoirs, latency and mechanisms of HIV persistence [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/YJLS3398.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert Siliciano has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.